Europe — EMA
Nulojix (Belatacept)
Belatacept, the active ingredient in Nulojix, is an immunosuppressant presented as an intravenous infusion for organ transplant use. It helps prevent rejection in kidney transplant recipients and is administered under…
Request sourcing
What is Belatacept?
Belatacept, the active ingredient in Nulojix, is an immunosuppressant presented as an intravenous infusion for organ transplant use. It helps prevent rejection in kidney transplant recipients and is administered under specialist supervision. GNH USA supplies Nulojix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.
GNH USA supplies Nulojix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.
What is Belatacept used for?
Nulojix is an immunosuppressant that acts on the immune response pathway to reduce organ rejection risk.
- Kidney transplantation: helps prevent the onset of acute and chronic rejection in adult recipients. - Kidney transplantation (maintenance phase): supports long‑term graft survival when used with standard immunosuppressive regimens. - Kidney transplant clinical trials in adult patients with high immun risk or non‑responsive to standard therapy : provid provid provid provid provid provid.
What are the side effects of Belatacept?
Nuloj ... ... ... ... ...
